| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4408457 | Chemosphere | 2015 | 7 Pages |
•A method for extraction of perfluorinated alkyl acids from serum was developed.•The method consists of SPE, liquid/liquid-extraction, HPLC and anion extraction.•The final serum PFAA fraction is free of endogenous estrogens.•Upon extraction, the actual PFAA-induced xenoestrogenicity can be determined.
Humans are exposed to perfluorinated alkyl acids (PFAAs) through food, drinking water, consumer products, dust, etc. The human metabolism and excretion of the long-chain PFAAs is slow with half-lives up to 8.8 years. Studies suggest that the PFAAs are potential endocrine-disrupting compounds that might affect human health.We developed a method for extraction of PFAAs from human serum with simultaneous removal of endogenous sex hormones. The developed method includes solid phase extraction, liquid/liquid extraction, HPLC fractionation and weak anion exchange. The method was validated by extraction of seven persistent PFAAs spiked to human male serum obtaining mean recoveries between 49.6% and 78.6%. Using an estrogen receptor (ER) transactivation luciferase reporter gene assay, analysis of the extracted PFAA serum fraction from three pregnant women showed the ER-active endogenous hormones were removed.The developed method was further documented by extraction of the PFAAs from the serum of 18 Danish pregnant women. The PFAA fraction from three of the 18 samples significantly induced the ER-transactivity. Upon co-exposure with the natural ER-ligand 17β-estradiol (E2), 17 of the 18 PFAA fractions caused a significant further increase of the E2 induced ER-transactivity. In conclusion, we developed a method to extract PFAAs from human serum, and the method documentation suggested that PFAAs at the levels found in human serum can transactivate the ER.
